Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Relay Therapeutics, Inc. Common Stock | RLAY

Daily Technical Analysis of Relay Therapeutics, Inc. Common Stock

Relay Therapeutics is up a bit on the day, funds flowing in kept the price up 1.23% since yesterday.

Currently RLAY isn't at a clear support/resistance line that seems tradable. Relay Therapeutics hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. RLAY might find some support at the 7.83 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-03-17

Analyst Ratings for Relay Therapeutics By Price Target And Rating

The analysts feel fairly neutral on the prospects for Relay Therapeutics but a little more positive than negative. The current Analysts Sentiment Score is 11.98. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. HC Wainwright announced a lowering of their price target to $17.00 from $19.00 on 2023-12-11. Oppenheimer reiterated a rating of Outperform on 2023-08-09 and added a price target of $33.00. SVB Securities initiated a rating of Outperform on 2023-08-08. Leerink Partnrs reiterated a rating of Outperform on 2023-08-08. JMP Securities announced a lowering of their price target to $24.00 from $28.00 on 2023-05-05. On 2023-04-20 Stifel Nicolaus lowered their price target by -10.53% to $34.00. Jefferies Financial Group upgraded from Underperform to Hold on 2023-04-20 but they lowered their price target by -21.88% to $12.50 from a previous target of $16.00. On 2023-04-19 Barclays lowered their price target by -34.78% to $15.00. Raymond James upgraded from Outperform to Strong-Buy on 2023-04-19 and added a price target of $29.00. JPMorgan Chase & Co. provided a price target decease of -30.95% to $29.00 from $42.00 on 2023-04-19.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
RLAY11.9826.609.64-12.28

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-03-23)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
RLAY0.000.00

Short interest for Relay Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
RLAY11.39%16.313.5-40.52413770000

Social Sentiment for Relay Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
RLAY

Companies with the highest correlation to Relay Therapeutics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
LMND | Lemonade, Inc.0.881.882.89-1.912.3241.9826.12417.0015.5417.59-14597.61-3480.950023.9383
SAGE | Sage Therapeutics, Inc0.86-1.68-2.60-14.36-13.61-9.65-57.2027-22.06-22.77-15.93-51237.60-1298.120012.6533
CRSP | CRISPR Therapeutics AG0.86-2.02-4.01-17.929.8845.8556.761257.6450.1337.40-2101.92-9760.98015015.3247
TDOC | Teladoc Health, Inc.0.850.332.132.13-27.87-17.32-38.7943-24.98-33.71-40.36-27887.95-843.48008.78425
EDIT | Editas Medicine, Inc. Com0.83-0.39-0.79-29.62-21.747.100.01261.11-0.78-6.75-18653.05-1877.60010016.4101
YMAB | Y-mAbs Therapeutics, Inc.0.83-0.641.02-12.28149.54193.82406.0220121.4467.8557.01-4077.37-18649.020010.5121
FATE | Fate Therapeutics, Inc.0.822.0413.31-3.23111.58243.5834.9542190.8648.0232.47-27079.19-7042.22007.69285

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-